Salofalk^® (mesalazine) is used to treat active UC and maintain patients in remission and is available in 2 oral and 3 rectal formulations:

For oral administration Salofalk^® granules – prolonged release formulation available in 3g, 1.5g, 1g and 500mg sachets Salofalk^® tablets – gastro-resistant formulation available as 1g, 500mg and 250mg tablets For rectal administration Salofalk^® 2g liquid enema (4g enema, Ireland) Salofalk^® 1g rectal foam Salofalk^® 500mg and 1g suppositories.